» Articles » PMID: 12559046

Regulation of BRCA1 Expression and Its Relationship to Sporadic Breast Cancer

Overview
Specialty Oncology
Date 2003 Feb 1
PMID 12559046
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Germ-line mutations in the BRCA1 tumour suppressor gene contribute to familial breast tumour formation, but there is no evidence for direct mutation of the BRCA1 gene in the sporadic form of the disease. In contrast, decreased expression of the BRCA1 gene has been shown to be common in sporadic tumours, and the magnitude of the decrease correlates with disease progression. BRCA1 expression is also tightly regulated during normal breast development. Determining how these developmental regulators of BRCA1 expression are co-opted during breast tumourigenesis could lead to a better understanding of sporadic breast cancer aetiology and the generation of novel therapeutic strategies aimed at preventing sporadic breast tumour progression.

Citing Articles

Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer.

Xie Y, Xiao D, Li D, Peng M, Peng W, Duan H Front Oncol. 2024; 14:1441222.

PMID: 39156700 PMC: 11327142. DOI: 10.3389/fonc.2024.1441222.


Methyl CpG binding protein MBD2 has a regulatory role on the BRCA1 gene expression and its modulation by resveratrol in ER+, PR+ & triple-negative breast cancer cells.

Sahu R, Tandon S, Singh S, Das B, Hedau S BMC Cancer. 2024; 24(1):566.

PMID: 38711004 PMC: 11071212. DOI: 10.1186/s12885-024-12274-x.


A transcription-independent mechanism determines rapid periodic fluctuations of BRCA1 expression.

Nie C, Zhou X, Zhou J, Liu Z, Gu Y, Liu W EMBO J. 2023; 42(15):e111951.

PMID: 37334492 PMC: 10390875. DOI: 10.15252/embj.2022111951.


Landscape of NcRNAs involved in drug resistance of breast cancer.

Kang Y Clin Transl Oncol. 2023; 25(7):1869-1892.

PMID: 37067729 PMC: 10250522. DOI: 10.1007/s12094-023-03189-3.


Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage.

Wu X, Guo M, Cui J, Cai H, Wang S Oncogenesis. 2022; 11(1):41.

PMID: 35869059 PMC: 9307611. DOI: 10.1038/s41389-022-00417-3.


References
1.
Troyer K, Lee D . Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia. 2001; 6(1):7-21. DOI: 10.1023/a:1009560330359. View

2.
Dimitrov S, Matouskova E, Forejt J . Expression of BRCA1, NBR1 and NBR2 genes in human breast cancer cells. Folia Biol (Praha). 2001; 47(4):120-7. View

3.
DiNardo D, Butcher D, Robinson D, Archer T, Rodenhiser D . Functional analysis of CpG methylation in the BRCA1 promoter region. Oncogene. 2001; 20(38):5331-40. DOI: 10.1038/sj.onc.1204697. View

4.
Fata J, Leco K, Voura E, Yu H, Waterhouse P, Murphy G . Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest. 2001; 108(6):831-41. PMC: 200934. DOI: 10.1172/JCI13171. View

5.
Parrinello S, Lin C, Murata K, Itahana Y, Singh J, Krtolica A . Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J Biol Chem. 2001; 276(42):39213-9. DOI: 10.1074/jbc.M104473200. View